Huntington's disease
β Scribed by David Craufurd
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 873 KB
- Volume
- 16
- Category
- Article
- ISSN
- 0197-3851
No coin nor oath required. For personal study only.
β¦ Synopsis
Huntington's disease (HD) is a late-onset degenerative disorder of the central nervous system, caused by a dominantly inherited mutation in a gene on chromosome 4p. The identification of the trinucleotide repeat mutation responsible for this disorder has been an important step towards understanding the molecular pathology of HD, but in the meantime has also made it possible to offer predictive testing and prenatal diagnosis to individuals at high genetic risk. Predictive testing offers obvious benefits for those who receive a favourable result, but also runs the risk of significant psychological and social problems for the families involved. Uptake of testing to date has been limited. Prenatal testing where the pregnancy is at 25% risk carries the same disadvantages as adult predictive testing, because an unfavourable result would also establish that the at-risk parent is a gene carrier; prenatal exclusion testing offers an alternative method of detecting and terminating at-risk pregnancies without revealing the genetic status of the at-risk parent.
π SIMILAR VOLUMES
jections 7 and single cell recording studies in putamen and pallidum of primates, 8 and also in humans during stereotaxic surgery. 9 Also, it is important in this differing topography that the changes in dopaminergic input into the striatum in Parkinson's disease affect the caudate and putamen in a
## Abstract The authors report a patient with Huntington's disease (HD) presenting with severe chorea. The motor scale of the unified HD rating scale (UHDRSβI) revealed 81 points. Motor function clearly improved with zotepine, until she reached an UHDRSβI of 34 points on day 7 of treatment. The pat
## Abstract Motor activity was quantitatively assessed over a period of 5 days using a wristβworn activity monitor in 14 patients with Huntington's disease (of whom 4 used neuroleptic drugs) and 14 age and sexβmatched healthy controls. Additionally, patients were rated for dementia, depression, cli